The translocation t(2;5)(p23;q35), discovered in CD30' anaplastic large cell (ALC) lymphomas, creates a potentially oncogenic fusion gene, part of which is contributed by a novel tyrosine kinase, ALK. Absence of ALK expression from normal hematolymphoid cells provides a basis for the morphologic assessment of t(2;5). The distribution of the t(2;5) in ALC lymphomas and Hodgkin's disease (HD), as assayed by nonmorphologic methods, is controversial. We used in situ hybridization andlor immunohistology to show ALK gene products in 85 ALC lymphomas, 82 HD cases, 40 other lymphoproliferations, as well as in 6 HD-and 4 ALC lymphomaderived cell lines. ALK gene products were restricted to t(2;5)-positive ALC lymphoma cell lines and tumor cells of D30' ANAPLASTIC large cell (ALC) lymphomas represent a recently recognized entity of high-grade nonHodgkin's lymphomas (NHL), arising as primary lymphonodal and extranodal neoplasms or secondary to non-ALC NHL and Hodgkin's disease (HD).'-4 In their most prototypic form ("common" type), ALC lymphomas are characterized by CD30+ tumor cells with abundant cytoplasm, large irregular nuclei, and prominent, sometimes rod-shaped, nucleoli.',2 In cases with lymphonodal involvement, these tumor cells typically grow in coherent sheets with a sinusoidal dissemination, initial infiltration of the parafollicular areas, and sparing of germinal centers.',' Although displaying distinct morphologic features, ALC lymphomas share a number of properties with HD, such as cytomorphologic similarities with Hodgkin and Reed-Stemberg (H-RS) cells, the constitutive expression of activation markers, most notably the CD30 antigen, a bimodal age distribution in primary disease, and the association with Epstein-Barr virus in a proportion of In some ALC lymphomas additional features of HD may be present such as fibrosis, capsule thickening, CD15 expression by tumor cells, and a variably heterogeneous reactive cellular admixture. These cases, many of which may previously have been diagnosed as lymphocytedepleted HD, are now classified as HD-related or HD-like ALC l y m p h~m a .~,~ Because of this heterogeneity among ALC lymphomas and the diagnostic dilemma of distinguishing between such lymphomas and tumor cell-rich HD, the observation of a characteristic reciprocal translocation involving chromosomes 2 and 5 , t(2;5)(p23;q35), in ALC lymphomas has attracted By cytogenetic analysis, the t(2;S) seemed to be unique to ALC lymphoma associated with a non-B cell phenotype and genotype6"' and it was not found in any of over 100 cytogenetically analyzed HD cases.'"" However, because of the technical difficulty of reliably assigning abnormal karyotypes to H-RS cells, it is conceivable that this translocation may have been missed in HD. Thus, many questions relating to the clinical and biologic significance of the t(2;5) and their distribution among CD30+ lymphomas remained open. Now, these issues may be addressed by molecular methodology after cloning of the t(2; 5 ) breakpoint regions has been achieved.14 The chromosomal disruptions were found to occur each within the introns of two unique loci. The gene at region 5q35 was identified as nucleophosmin (NPM), a cellcycle regulated and ubiquitously expressed nucleolar phosphoprotein involved in shuttling ribosomal components between the nucleolus and the cytoplams. The downstream sequences of the t(2; 5)-fusion gene product are derived from a novel tyrosine kinase gene with similarity to receptor proteins such as the insulin re~eptor.'~ Physiologically, this novel gene, designated ALK (anaplastic lymphoma kinase), is expressed in brain, gut, testis, and rhabdomyosarcoma cell lines, but not in hematolymphoid cells.I4 Expression of ALK sequences in lymphoid lesions seems to be restricted to cells carrying the t(2;5) or other aberrations involving chromosomal region 2p23 and may therefore serve as a phenotypic tumor marker. In the t(2;5), expression of the fusion gene is controlled by the NPM promoter, resulting in cell-cycledependent expression of a truncated, constitutively activated, putatively oncogenic ALK k i n a~e . '~~'~ Because of the variable intronic localization of the breakpoints on both chromosomes, the t(2;5) cannot be conveniently shown by polymerase chain reaction (PCR) at the genomic level. Both t(2;5) breakpoint junctions are spliced out during RNA transcript processing, giving rise to a fusion mRNA with invariant breakpoint junctions corresponding to
16 primary non-B cell, common-type ALC lymphomas. These were mainly from young patients with initial lymphonodal disease. ALK expression was not detectable in any other specimen, including all cases of HD and HD-like type ALC lymphoma as well as secondary ALC lymphomas. Full congruence was noted for labeling results obtained with both methods. In agreement with cytogenetic analyses, but at variance with recently published studies, ALK gene expression distinguishes a subset of ALC lymphomas from other CD30+ lymphomas, including HD. The results do not support concepts attributing a significant role to the t(2;5) in the development of HD. Q 1% by The American Society of tfematology.
and the diagnostic dilemma of distinguishing between such lymphomas and tumor cell-rich HD, the observation of a characteristic reciprocal translocation involving chromosomes 2 and 5 , t(2;5)(p23;q35), in ALC lymphomas has attracted By cytogenetic analysis, the t(2;S) seemed to be unique to ALC lymphoma associated with a non-B cell phenotype and genotype6"' and it was not found in any of over 100 cytogenetically analyzed HD cases.'"" However, because of the technical difficulty of reliably assigning abnormal karyotypes to H-RS cells, it is conceivable that this translocation may have been missed in HD. Thus, many questions relating to the clinical and biologic significance of the t(2;5) and their distribution among CD30+ lymphomas remained open. Now, these issues may be addressed by molecular methodology after cloning of the t(2; 5 ) breakpoint regions has been achieved.14 The chromosomal disruptions were found to occur each within the introns of two unique loci. The gene at region 5q35 was identified as nucleophosmin (NPM), a cellcycle regulated and ubiquitously expressed nucleolar phosphoprotein involved in shuttling ribosomal components between the nucleolus and the cytoplams. The downstream sequences of the t(2; 5)-fusion gene product are derived from a novel tyrosine kinase gene with similarity to receptor proteins such as the insulin re~eptor.'~ Physiologically, this novel gene, designated ALK (anaplastic lymphoma kinase), is expressed in brain, gut, testis, and rhabdomyosarcoma cell lines, but not in hematolymphoid cells.I4 Expression of ALK sequences in lymphoid lesions seems to be restricted to cells carrying the t(2;5) or other aberrations involving chromosomal region 2p23 and may therefore serve as a phenotypic tumor marker. In the t(2;5), expression of the fusion gene is controlled by the NPM promoter, resulting in cell-cycledependent expression of a truncated, constitutively activated, putatively oncogenic ALK k i n a~e . '~~'~ Because of the variable intronic localization of the breakpoints on both chromosomes, the t(2;5) cannot be conveniently shown by polymerase chain reaction (PCR) at the genomic level. Both t(2;5) breakpoint junctions are spliced out during RNA transcript processing, giving rise to a fusion mRNA with invariant breakpoint junctions corresponding to exonic b~undaries.'~ Detection of NPM rearrangements by Southern blot hybridization and reverse transcription followed by PCR (RT-PCR) of NPM-ALK transcripts have already been applied to a limited number of ALC lymphomas and HD cases with contradictory result^.'^*'"*^ HD patients may be prone to chromosomal instability, and it is therefore conceivable that the detection of NPM-ALK transcripts in HD biopsy samples may reflect translocations occurring outside the tumor cell population. These uncertainties and the lack of morphologic information prompted us to address the question as to the cellular localization of ALK gene transcripts in ALC lymphoma and HD biopsy specimens.
Because of the absence of ALK expression in normal hematolymphoid cells,I4 the t(2; 5) lends itself to the application of morphologic techniques even on archival materials by detection of ALK gene products in situ. We used ALK RNA probes for in situ hybridization on t(2; 5)-positive cell lines, HD-derived cell lines, 82 HD cases, and 85 ALC lymphomas representing different histologic types and immunophenotypes. Controls consisted of non-ALC high-grade NHL with variable, but usually small, numbers of CD30+ cells as well as lymphoid tissue with reactive lesions. Additionally, detection of ALK protein was achieved by immunohistology with an antibody specific for the ALK kinase domain as present in the p80 NPM-ALK chimaeric fusion protein."
MATERIALS AND METHODS
Tissues. Paraffin-embedded tissue blocks representing 207 cases of ALC lymphoma, HD, NHL, and nonmalignant lesions (Table 1) were drawn from the files of the Institute of Pathology at the Klinikum Benjamin Franklin, Free University Berlin. Tissues were fixed with neutral-buffered formalin, and embedded in paraffin by routine procedures. Paraffin blocks of 14 human T-lymphotropic virus-I (HTLV-I)-associated adult T-cell lymphomas (ATL) were a kind gift of Dr A. Micata (Chiba, Japan). 5 pm sections were cut onto RT-PCR and generation of in situ hybridization probes. Total RNA was extracted from cell lines, digested with DNase I, and transcribed to cDNA using random hexamere primers and reverse transcriptase from Moloney murine leukemia virus (Perkin-Elmer Cetus, Weiterstadt, Germany). In brief, 1 pg of total cellular RNA was incubated for 25 minutes at 42°C with 50 U of reverse transcriptase and 20 U placental RNase inhibitor in a 20-pL v01 containing 2.5 pmoVL random primers, 5 mmoW MgC12, 50 mmoVL KCl, 10 mmoVL Tris-HCI, and 1 mmoVL each of deoxynucleosidetriphosphates, heated to 99°C and subsequently cooled at 5°C for 5 minutes each. Oligonucleotide primers corresponding to positions 566 through 585 (primer l , 5"AGGTGTATGAAG-GCCAGGTG-3') and 1004 through 1023 (primer 2, 5"GCTC-GCCCTGTAGATGTCTC) as well as 934 through 953 (primer 3, (primer 4, 5'-GCCTGlTGAGAGACCAGGAG) of the published ALK sequence14 were synthesized. Primer pairs 112 and 3/4 were used to obtain PCR amplification products of 457 bp and 535 bp, respectively. The PCR reaction mixture consisted of 1.5 mmoVL MgCI2, 50 mmoVL KCl, 10 mmoVL TFUS-HCI, each 0.2 pmoVL of both primers, 2.5 U of Taq DNA polymerase (Perkin-Elmer Cetus) in a 0.1-mL v01 containing 20 pL of the above-mentioned RT reaction mixture. Reaction conditions were each l minute at 96°C and 6WC, and 2 minutes at 72°C for 30 cycles followed by a final extension for 10 minutes at 72°C. For control, a 289-bp product corresponding to sequences of the P-actin genez8 was amplified from cDNA after RT. The P-actin primer sequences were 5"CGGAACplification was performed with 30 cycles at 95' C and 54°C for each 1 minute and 72°C for 2 minutes followed by a final extension for 10 minutes at 72°C. Amplification products from the cell line SU-DHL-1 were cloned into the run-off transcription vector pAMPl (GIBCO-BRL, Eggenstein, Germany) and subjected to automated nucleotide sequence determination. The sequences were found to conform to the published ALK sequence.I4
In situ hybridization. In situ hybridization was performed as previously described.29 After linearization of the pAMPl constructs with appropriate restriction enzymes, antisense and sense (control) RNA probes were generated by run-off transcription with incorporation of [35S]-labeled nucleotides yielding an average specificity of 1.3 X IO9 c p d p g . Both ALK RNA probes were applied independently as well as in combination to achieve maximum sensitivity in extended exposure experiments. EBERI-and EBER2-specific pBluescriptbased vectors, kindly provided by Dr G . Niedobitek (Birmingham, UK), prepared from plasmids pJJJl and pJJJ2, were used as described.29
Immunohistology. Immunhistologic detection of p80 was performed using an affinity-purified rabbit antibody directed at the sequence SNQEVLEFVTSGGR corresponding to the putative ALK kinase domain." The antibody was kindly made available to us before commercial distribution by Nichirei CO (Tokyo, Japan), through Dm M. Shiota and S . Mori (Tokyo, Japan), and applied in a 150 dilution to deparaffinized sections that were previously subjected to high-pressure cooking for antigen retrieval. Normal rabbit serum served as control. Immobilized rabbit antibody was detected with affinity-purified mouse-antirabbit biotinylated antibodies, streptavidin-conjugated peroxidase, and 3.3'-diaminobenzidine tetrahydrochloride as chromogen. Immunophenotypic analysis of lymphoid lesions was routinely performed using the alkaline phosphataselantialkaline phosphatase (APAAP) technique with the monoclonal antibodies Ber-H2 (CD30). L26 (CD20), C3Dl (CD15). PG-MI (CD68). PFI (specific for the T-cell antigen receptor 8-chain), CS1.4 (detecting the Epstein-Barr virus latent membrane protein-l, LMPI), and a rabbit-antibody against the CD3 antigen. With the exception of PFI, which was from T-cell Sciences (Cambridge, MA), all primary antibodies as well as secondary reagents and chromogens were purchased from DAKO (Glostrup, Denmark).
RESULTS

Cell lines. PCR
amplification of cDNA obtained from all four t(2;5)-bearing cell lines, JB6, DEL, SU-DHL-l, and Karpas 299, with primer pairs 1/2 and 3/4 resulted in products of 457 bp and 535 bp, respectively (Fig 1) . No PCR products were amplifiable from the HD-derived cell lines L540, L591, Ho, CO, and KM-H2 with these sets of primers, HERBST ET AL whereas control RT-PCR reactions for the RT of actin mRNA and amplification of cDNA sequences displayed the presence of sufficient amounts of RNA. In situ hybridization showed positive signals only in cytocentrifuge preparations from the t(2;5)-canying cell lines with both independently applied RNA antisense probes, whereas sense-probes on t(2;5)-positive cell lines resulted in background signal. No specific in situ hybridization signal was obtained with any of the HD-derived cell lines, L428, L540, K591, CO, Ho, and KM-H2 (Fig 2) .
CD30' ALC lymphomas. A total of 85 ALC lymphomas was tested by in situ hybridization using ALK-specific RNA probes (81 cases) and/or p80-specific immunohistology (19 cases). Ten cases displayed clear in situ hybridization signals exclusively over tumor cells ( Table 1, Figs 2 and 3) . Both ALK antisense probes produced signals of similar intensity.
Sense control RNA hybridizations resulted in background signal. Because of the limited amount of p80-specific antibody available, only a small number of selected ALC lymphomas could be tested by immunohistology. Reactivity with the p80-specific antibody was entirely restricted to ALC lymphoma cells in 15 cases (Fig 3) . Nine of these cases were ALC lymphomas previously found to express ALK RNA transcripts, thus providing additional validation of the in situ hybridization results. The other 10 cases displayed commontype morphology. They were studied only by immunohistology because only few paraffin sections were available.
All of the ALK-positive ALC lymphomas were of non-B phenotype, morphologically conforming to the common type of ALC lymphomas. The median patient age was 24 years, with a range from 8 to 52 years. Fourteen of 16 ALK-positive ALC lymphomas were primary nodal neoplasias; only 2 cases represented primary extranodal disease in sceletal muscle and parotid gland, respectively. Among common-type ALC lymphomas, ALK-positive tumors represented a proportion of approximately one third of our cases. The histologic, phenotypic, and topographic characteristics of the ALC lymphomas of the present series are listed in Table 2 . All ALC lymphomas of HD-like or lymphohistiocytic type, and those known to have developed secondary to HD or non-ALC NHL, did not display ALK expression. Interestingly, ALK-positive ALC lymphomas proved to be morphologically indistinguishable from ALK-negative T-/"Null" -cell ALC lymphomas of common-type histology, but the latter cases were often from patients with advanced age (median 36 years, range 11 to 80 years).
HD. A total of 82 HD biopsy samples was studied for the presence of ALK gene products. In situ hybridization was performed on 77 cases with both independently applied ALK RNA probes. Seventy-one HD cases, 66 of which had also been tested by in situ hybridization, were stained with the p80-specific antibody. Neither in situ hybridization nor immunohistology provided evidence for the presence of ALK or NPM-ALK gene products in any of the HD cases, even when both of the ALK RNA probes were used in combination with autoradiographic exposure times up to 12 weeks. The HD biopsy samples represented all four histologic types recognized by the Rye classification and comprised cases with B-, T-, or "Null"-cell phenotype (14, 11, and 57 cases, were related to human immunodeficiency virus infection,
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From and all T-NIU were related to HTLV-I infection. Six tonsils with moderate follicular andor extrafollicular hyperplasia as well as four tonsils from patients with clinically established infectious mononucleosis were tested by in situ hybridization. Two infectious mononucleosis tonsils were additionally studied by immunohistology with the p80-specific antibody. All of these control tissues did not provide any evidence of ALK or NPM-AM gene expression ( Table 1) .
DISCUSSION
The reciprocal translocation, t(2;5)(p23;q35), results in fusion of the NPM and ALK genes with the subsequent expression of chimaeric NPM-ALK RNA and ~r0tein.l~ Because of the absence of ALK gene expression in hematolymphoid cells, detection of RNA and protein derived from the 3' portion of the ALK gene is indicative of the t(2;5)14 or other aberrations resulting in activation of the ALK gene. We have studied the expression of ALK RNA in 85 ALC lymphomas, 82 HD cases, as well as 30 high-grade non-ALC NHL and 10 nonmalignant lymphoid lesions by in situ hybridization using [35S]-labeled single-stranded RNA probes specific for 3' ALK sequences. We used an isotopic in situ hybridization procedure for these studies with extended autoradiographic exposure times to achieve a maximum of sensitivity for the detection of even low transcript copy num- Expression of ALK gene products was restricted to primary non-B cell ALC lymphomas of predominantly young patients. These cases showed the morphology of commontype ALC lymphoma, and most of them represented primary lymphonodal disease. However, primary extranodal tumors were also found among ALK-positive ALC lymphomas. All cases of secondary ALC lymphomas, HD-like ALC lymphomas, and ALC lymphomas of B-cell phenotype did not display expression of ALK gene products. ALK-negative and -positive ALC lymphomas of common type were morphologically indistinguishable. Judging from cytogenetically analyzed cases, ALK-positive, ie, t(2;5)-bearing cases, are likely to represent a clinically distinct group of ALC lymphomas with good response to chemotherapy."'o Thus, ALK expression seems to characterize a distinct subset of ALC lymphomas and may warrant its recognition as a separate group among ALC lymphomas. In consequence, determination of ALK expression may prove useful in the diagnostic evaluation of ALC lymphomas.
In agreement with cytogenetic dat.a,' "' 3.30 all of our HD cases as well as HD-like types of ALC lymphomas did not express ALX gene products coded for by the 3' portion of the gene at levels detectable by our in situ hybridization
For personal use only. on August 30, 2017. by guest www.bloodjournal.org From procedure. The HD cases comprised all histologic types as well as cases of B-, T-and "Null"-cell phenotype and also included Epstein-Barr virus-positive and -negative cases. Case number and intrinsic variability of the present HD series seem to rule out inadvertent exclusion of a putative t(2;5)-positive subgroup of HD that, in analogy to ALC lymphomas, eg, may have comprised cases with T-phenotype in young patients.
The distribution of the t(2;5) is controversial. Recently published studies cover a limited number of ALC lymphomas and HD cases subjected to molecular t(2;5) analyfound NPM gene rearrangements in one ALC lymphoma of B-cell phenotype and in two HD cases, one of which was of lymphocyte predominance histotype (HDlp). This is interesting because this histotype of HD differs from classical HD in many aspects and is now considered to represent a B-lymphoid disorder distinct from the other types of HD? However, it is possible that the NPM gene rearrangements in these cases were not caused by the t(2;5), but reflected other aberrations not involving the ALK gene. This interpretation is supported by the previous observation of one HD case with aberrations within the 5q35.30 More controversial are the data showing presence or absence of NPM-ALK chimeric RNA by RT followed by PCR (RT-PCR) in HD. Ladanyi et a l l s did not observe such transcripts in any of 40 HD cases. At variance with these and our data, Orscheschek et a l l 9 found NPM-ALK transcripts in 11 of 13 HD cases. Unfortunately, phenotypic and other characteristics of the NPM-ALK-positive HD cases were not reported in the latter study, so the reason for the discrepancies are not clear. At balance, however, current evidence suggests that transcripts representing part of the ALK gene are found, if at all, in only occasional cases of HD.
Therefore, the t(2;5) is unlikely to be the oncogenic principle common to the broad spectrum of CD30+ lymphomas. The molecular pathogenesis of typical HD and ALK-expressing common-type ALC lymphoma seems to be distinct, despite the numerous cytomorphologic and immunophenotypic parallels documenting the close relationship between these entities. The NPM-ALK product p80 apparently interferes at a pivotal point with intracellular signal transduction pathways generating an activated CD30+ phenotype. In this cellular context CD30 expression may be secondary and paracrine stimulatory effects such as CD30KD30-ligand interaction may not be required for cellular growth. In typical HD, on the other hand, paracrine mechanisms between CD30 and other growth factor receptors and their ligands seem to be relevant to maintain H-RS cells in an activated state. This interpretation is in keeping with the previously noted stimulatory effects of CD30-ligand for HD-derived cell lines, but of inhibitory effects for ALC lymphoma celk3' Differences between typical HD and common-type ALC lymphomas are also reflected by their growth patterns in lymphoreticular tissue. Before destroying the tissue by direct tumor growth, primary ALC lymphomas infiltrate lymph nodes in a pattern simulating the distribution of CD30+ antigen-activated extrafollicular blasts. In contrast, typical HD lesions are not the result of direct, destructive H-RS cell growth but sis.14,16-19 At variance with our present data, Bullrich et a l l 6 rather due to architectural reorganization likely to be caused by abnormal cytokine secretion.' Further analysis of the NPM-ALK fusion protein and its substrates may be expected to shed light on intracellular signal transduction pathways leading to the CD30+ activated phenotype. Although present in only a subgroup of ALC lymphomas and obviously irrelevant for the majority of HD cases, the t(2;5) aberration and the resulting p80 phosphoprotein may hold the key to a better understanding of the biology and molecular pathogenesis of all CD30+ lymphomas.
